The most recent guidelines for the management of Barrett's oesophagus published in 2014
recommended endoscopic surveillance for patient with histological evidence of low-grade …

Objective Reported malignant progression rates for low-grade dysplasia (LGD) in Barrett's
oesophagus (BO) vary widely. Expert histological review of LGD is advised, but limited data …

The purpose of this clinical practice update expert review is to define the key principles in
the diagnosis and management of low-grade dysplasia (LGD) in Barrett's esophagus …

Background Reported incidence rates of oesophageal adenocarcinoma (OAC) in Barrett's
oesophagus (BO) vary widely. As the effectiveness of BO surveillance is crucially dependent …

These guidelines provide a practical and evidence-based resource for the management of
patients with Barrett's oesophagus and related early neoplasia. The Appraisal of Guidelines …

Background & Aims In patients with Barrett's esophagus (BE), low-grade dysplasia (LGD) is
a risk factor for esophageal adenocarcinoma (EAC), progressing at variable rates. Patients …

Background & Aims In some patients with Barrett's esophagus (BE) and a confirmed
diagnosis of low-grade dysplasia (LGD), the LGD is not detected during follow-up …

Oesophageal adenocarcinoma has a low incidence and still remains an uncommon cancer;
however, it has been on the rise over the past 20 years. Barrett's oesophagus, a …

Background & Aims For patients with Barrett's esophagus, the diagnosis of low-grade
dysplasia (LGD) is subjective, and reported outcomes vary. We analyzed data from a …

OBJECTIVES: Published data on the natural history of low-grade dysplasia (LGD) in
Barrett's esophagus (BE) are inconsistent and difficult to interpret. We investigated the …